A pharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists or primary care physicians.
The best Bull and Bear pitches based on recency and number of recommendations.
FDA will not approve... Inside info boys!!!Will lose 20-25 pct easily, FDA will need more data
Read the most recent pitches from players about SNTS.DL.
Find the members with the highest scoring picks in SNTS.DL.
See what the Wall Street professionals think, according to their public statements and filings.